Bupropion HCL Tablet
Bupropion is prescribed for dogs and cats to support behavioral health. It helps manage stress, anxiety, and other behavioral concerns by providing steady, long-lasting calming support.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider bupropion hydrochloride in the context of behavioral health protocols where a non-sedating approach to mood regulation is a clinical objective. It is frequently a point of discussion for pets presented with separation anxiety, compulsive disorders or in some cases, as a secondary option for the management of attention-deficit-type behaviors. While the medication has been studied for various applications, its use in veterinary medicine is often based on clinical awareness of its unique neurotransmitter profile.
At a pharmacological level, bupropion acts as a selective norepinephrine and dopamine reuptake inhibitor (NDRI). By blocking the transporters responsible for the reabsorption of these neurotransmitters, the medication manages the concentration of dopamine and norepinephrine in the synaptic cleft. Unlike many other antidepressants used in pets, bupropion does not significantly influence serotonin levels or bind to histamine or adrenaline receptors. This specific action shapes its physiological profile as an activating or stimulating antidepressant rather than a sedating one. Your veterinarian will determine the clinical appropriateness of bupropion based on your pet’s species, behavioral history and the results of a comprehensive physical evaluation.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of bupropion hydrochloride include localized digestive changes such as a decrease in appetite or vomiting. Some pets may exhibit behavioral shifts including increased agitation, restlessness or insomnia, which are associated with the medication's stimulating mechanism. In feline patients, veterinarians monitor closely for potential neurological sensitivity. Owners should watch for any tremors or sudden behavioral changes and contact their veterinarian promptly if these occur.
This medication is typically used with extra caution or avoided in patients with a history of seizures or epilepsy, as bupropion is known to lower the seizure threshold in several species. It is also carefully evaluated in patients with known liver or kidney impairment, as these organs are responsible for the metabolism and excretion of the medication. Significant interactions can occur when bupropion is used concurrently with monoamine oxidase inhibitors (MAOIs) or other medications that influence the central nervous system. Before starting use, ensure your veterinarian has a complete history of all other medications and supplements your pet is receiving. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most commonly considered monitoring schedule to ensure the management approach remains suitable for your pet's individual needs.
Yes. Bupropion hydrochloride is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all veterinarian-client-patient relationships before any medication is prepared or shipped.
Yes. While bupropion is available in several commercial tablet formats intended for human use, Mixlab can compound the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids or smaller capsules—to suit the specific needs of dogs and cats. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Bupropion belongs to a different class of medications called NDRIs, whereas medications like Prozac (fluoxetine) are SSRIs. While both are considered for behavioral management, bupropion targets dopamine and norepinephrine rather than serotonin, which is why your veterinarian may discuss it as a distinct option for your pet's specific profile.
The most important observational signs to monitor include tremors, excessive restlessness or a sudden loss of appetite after starting the medication. Because this medication can influence the seizure threshold, you should contact your veterinarian immediately if you observe any unusual twitching or neurological shifts.
